Clinical trial
Feasibility Study of Aastrom Tissue Repair Cells to Treat Non-Union Fractures.
NCT00424567 · Vericel Corporation, Industry · Terminated
Key facts
| NCT number | NCT00424567 |
|---|---|
| Title | Feasibility Study of Aastrom Tissue Repair Cells to Treat Non-Union Fractures. |
| Official title | TRC Autologous Bone Marrow Cells for the Treatment of Appendicular Skeletal Fracture Non-Union |
| Lead sponsor | Vericel Corporation, Industry |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Fracture, Ununited, Pseudarthrosis |
| Intervention type | Drug, Procedure |
| Interventions | Fracture surgery, Cultured Bone Marrow Tissue |
| Enrollment | 36 |
| Start date | Oct 1, 2003 |
| Completion | Jun 1, 2007 |
| First posted | Jan 19, 2007 |
| Last update posted | May 11, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: